ArticleFrontiers in oncology2021

Development of a Novel Anti-CD19 CAR Containing a Fully Human scFv and Three Costimulatory Domains.

Yupanun Wutti-In et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.